A made-in-India COVID vaccine, developed by Hyderabad-based firm Biological E could be 90% effective against COVID-19, an expert from a government advisory panel said. Dr. NK Arora said the vaccine is in phase three trials and could be available by October
newsbytesapp.com/news/india/bio…
Dr. Arora also added, "Bio E will be out likely in October with an efficacy matching Novavax's. In other words, 90 percent. They are moving to stage three trials soon (sic)," He also chairs the National Technical Advisory Group on Immunisation (NTAGI). #covidupdates
Biological E's vaccine, branded Corbevax, contains spike protein part of novel coronavirus. When the spike protein is injected, the body generates an immune response against it, thus helping the recipient fight off illness if they are exposed to the infection #COVIDVaccination
Reports say the government expects trials for Corbevax to be completed by July. It is also the first vaccine for which the Indian government has placed an advance order of Rs. 1,500 crore, despite a pending emergency use authorization.
Another exciting aspect is that Corbevax might be the most affordable COVID-19 vaccine in India and one of the cheapest across the globe. It is expected to cost just around Rs. 250 for both doses. #VaccineForAll
On a related note, India has three approved coronavirus vaccines - the indigenously-developed COVAXIN, Oxford-AstraZeneca's Covishield, and Russia's Sputnik V. #VaccinesWork
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.